286 related articles for article (PubMed ID: 31155370)
1. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.
Cheng CB; Zhang QX; Zhuang LP; Sun JW
Jpn J Clin Oncol; 2020 Sep; 50(10):1141-1149. PubMed ID: 32564084
[TBL] [Abstract][Full Text] [Related]
4. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
6. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
Eren T
ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
[TBL] [Abstract][Full Text] [Related]
8. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer.
Miyatani K; Sawata S; Makinoya M; Miyauchi W; Shimizu S; Shishido Y; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Fujiwara Y
BMC Cancer; 2022 Jun; 22(1):641. PubMed ID: 35690739
[TBL] [Abstract][Full Text] [Related]
11. Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer?
Angin YS; Yildirim M; Dasiran F; Okan I
ANZ J Surg; 2021 Jul; 91(7-8):1521-1527. PubMed ID: 33956378
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection.
Gu L; Wang M; Cui X; Mo J; Yuan L; Mao F; Zhang K; Ng DM; Chen P; Wang D
BMC Surg; 2020 Oct; 20(1):219. PubMed ID: 33008382
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
14. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study.
Zhang KP; Zhang X; Zhang Q; Ruan GT; Song MM; Xie HL; Zhang HY; Li XR; Yang M; Liu YY; Li QQ; Ge YZ; Liu XY; Lin SQ; Li W; Xu HX; Deng L; Shi HP
J Nutr Health Aging; 2022; 26(9):847-855. PubMed ID: 36156676
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
17. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
[TBL] [Abstract][Full Text] [Related]
18. Modified neutrophil-platelet score as a promising marker for stratified surgical and oncological outcomes of patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Omura Y; Kusunoki K; Yin C; Ide S; Kitajima T; Koike Y; Fujikawa H; Yasuda H; Okita Y; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Surg Today; 2020 Mar; 50(3):223-231. PubMed ID: 31485750
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of advanced lung cancer inflammation index, a nutritional and inflammation index, in gastric cancer patients after surgical resection: A propensity score matching analysis.
Yin C; Toiyama Y; Okugawa Y; Omura Y; Kusunoki Y; Kusunoki K; Imaoka Y; Yasuda H; Ohi M; Kusunoki M
Clin Nutr; 2021 Mar; 40(3):1130-1136. PubMed ID: 32773141
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
